Edward H. Eiland
Impact in
-
- Antibiotic Use and Resistance
- Clinical Biochemistry top 10%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antimicrobial Resistance in Staphylococcus 6
- Clostridium difficile and Clostridium perfringens research 2
-
- Bacterial Identification and Susceptibility Testing 8
- Co-authors
- Thomas M. English (3 shared papers)Lea S. Eiland (2 shared papers)Raymond A. Lorenz (1 shared paper)Kurt A. Wargo (3 shared papers)Keith S. Kaye (1 shared paper)Jerod Nagel (1 shared paper)James G. Stevenson (1 shared paper)Elizabeth D. Hermsen (2 shared papers)
- Journals
- Clinical Infectious Diseases (3 papers)Annals of Pharmacotherapy (2 papers)American Journal of Health-System Pharmacy (2 papers)American Journal of Kidney Diseases (1 paper)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Edward H. Eiland
17 papers receiving 372 citations
Peers
Comparison fields: 5 of 66
- Applied Microbiology and Biotechnology 68
- Clinical Biochemistry 49
- Infectious Diseases 120
- Pharmacology 83
- Nephrology 27
Countries citing papers authored by Edward H. Eiland
This map shows the geographic impact of Edward H. Eiland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward H. Eiland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward H. Eiland more than expected).
Fields of papers citing papers by Edward H. Eiland
This network shows the impact of papers produced by Edward H. Eiland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward H. Eiland. The network helps show where Edward H. Eiland may publish in the future.
Co-authors
The 20 scholars most cited alongside Edward H. Eiland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 88 | |
| 2 | 2013 | 69 | |
| 3 | 2006 | 60 | |
| 4 | 2014 | 43 | |
| 5 | 2014 | 38 | |
| 6 | Zanamivir for the prevention of influenza in adults and children age 5 years and older. | 2007 | 20 |
| 7 | 2014 | 14 | |
| 8 | 2014 | 12 | |
| 9 | 2017 | 10 | |
| 10 | 2010 | 9 | |
| 11 | Analysis of adherence to national nosocomial pneumonia treatment guidelines. | 2007 | 8 |
| 12 | 2008 | 4 | |
| 13 | 2005 | 3 | |
| 14 | 2010 | 3 | |
| 15 | 2008 | 2 | |
| 16 | 2014 | 2 | |
| 17 | 2011 | 2 | |
| 18 | 2007 | 1 | |
| 19 | 2008 | 0 | |
| 20 | 2008 | 0 |
About Edward H. Eiland
Edward H. Eiland is a scholar working on Infectious Diseases, Clinical Biochemistry, Applied Microbiology and Biotechnology, Pharmacology and Epidemiology, having authored 20 papers that have together received 388 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (8 papers), Bacterial Identification and Susceptibility Testing (8 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Antibiotic Resistance in Bacteria (4 papers), Patient Satisfaction in Healthcare (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers) and Cardiac electrophysiology and arrhythmias (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (68 citations), Clinical Biochemistry (49 citations), Infectious Diseases (120 citations), Pharmacology (83 citations) and Nephrology (27 citations). Edward H. Eiland has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Thomas M. English, Lea S. Eiland, Raymond A. Lorenz, Kurt A. Wargo, Keith S. Kaye, Jerod Nagel, James G. Stevenson, Elizabeth D. Hermsen, Patrick M. McDaneld and Katherine Lusardi. Their work appears in journals such as Clinical Infectious Diseases, Annals of Pharmacotherapy, American Journal of Health-System Pharmacy, American Journal of Kidney Diseases and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.